Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$1.15 - $1.89 $127,130 - $208,935
110,548 Added 316.98%
145,423 $202,000
Q4 2022

Feb 13, 2023

BUY
$0.96 - $1.6 $33,480 - $55,800
34,875 New
34,875 $39,000
Q2 2022

Aug 12, 2022

SELL
$0.67 - $1.4 $44,890 - $93,800
-67,000 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$1.23 - $3.31 $82,410 - $221,770
67,000 New
67,000 $82,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.